CVA-Chronic Kidney Disease Prevention and Management
There are many patients with proteinuria, CKD 3b, and 4 who have not been referred to Nephrology. Patients with reduced eGFR are not submitting urine studies. Patients with abnormal urinalyses are not receiving appropriate follow up.
100% patients with CKD stage 3b and 4 are referred to a Nephrologist. 100% patients with abnormal urinalyses receive appropriate follow up such as submitting additional urine studies. 100% patients with reduced eGFR submit urine studies.
- Participants will be able to recognize chronic kidney disease especially how proteinuria leads to faster progression of chronic kidney disease.
- Participants will be familiar with recommended CKD outreach workflow and utilize dot phrases to contact patients about chronic kidney disease.
- Participants will be able to communicate with patients about chronic kidney disease and refer patients to available online and in person educational resources about chronic kidney disease.
- Participants will be familiar with risk factors for development of chronic kidney disease and how we can work together to address these risk factors.
Disclosure: The presenter & planning committee members for this activity have disclosed that they have no relevant relationships with commercial or industry organizations. The CME Department has reviewed their disclosure information for the planner(s) and/or committee/faculty for this program and they do not have relationships that present a relevant conflict of interest. Kaiser Permanente does not endorse any brand name products.
Kaiser Permanente Central Valley is accredited by the Institute for Medical Quality/California Medical Association (IMQ/CMA) to provide continuing medical education for physicians. The Kaiser Permanente Central Valley designates this Live Activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.00 AMA PRA Category 1 Credit(s)™